SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3hdf'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 12 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
0.90A 1c6zA-3hdfA:
undetectable
1c6zA-3hdfA:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 12 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
1.00A 1fb7A-3hdfA:
undetectable
1fb7A-3hdfA:
19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HPV_B_478B200_2
(HIV-1 PROTEASE)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 9 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
1.04A 1hpvB-3hdfA:
undetectable
1hpvB-3hdfA:
18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HSH_A_MK1A401_1
(HIV-II PROTEASE)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
6 / 12 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A  94
ILE A 123
None
1.32A 1hshA-3hdfA:
undetectable
1hshA-3hdfA:
22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 12 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
0.95A 1hxbB-3hdfA:
undetectable
1hxbB-3hdfA:
18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OHR_A_1UNA201_1
(ASPARTYLPROTEASE)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 11 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
0.87A 1ohrA-3hdfA:
undetectable
1ohrA-3hdfA:
18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SDU_B_MK1B902_2
(PROTEASE RETROPEPSIN)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 12 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
0.98A 1sduB-3hdfA:
undetectable
1sduB-3hdfA:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AVS_B_MK1B902_3
(POL POLYPROTEIN)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 12 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
0.99A 2avsB-3hdfA:
undetectable
2avsB-3hdfA:
18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Z54_A_AB1A200_1
(HIV-1 PROTEASE)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 12 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
0.99A 2z54A-3hdfA:
undetectable
2z54A-3hdfA:
18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKX_B_1UNB201_2
(PROTEASE)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 11 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
0.87A 3ekxB-3hdfA:
undetectable
3ekxB-3hdfA:
18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 12 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
0.98A 3k4vC-3hdfA:
undetectable
3k4vC-3hdfA:
19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDU_A_ROCA101_1
(PROTEASE)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 12 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
0.93A 3nduA-3hdfA:
undetectable
3nduA-3hdfA:
19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S54_B_017B201_2
(PROTEASE)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
6 / 12 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A  94
ILE A 123
None
1.28A 3s54B-3hdfA:
undetectable
3s54B-3hdfA:
19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TKG_B_ROCB801_2
(PROTEASE)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 12 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
0.99A 3tkgB-3hdfA:
undetectable
3tkgB-3hdfA:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TKG_C_ROCC901_1
(PROTEASE)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 12 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
1.01A 3tkgC-3hdfA:
undetectable
3tkgC-3hdfA:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LL3_A_017A202_2
(PROTEASE)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 9 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
1.15A 4ll3B-3hdfA:
undetectable
4ll3B-3hdfA:
18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KR2_A_ROCA101_2
(PROTEASE PR5-SQV)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 11 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
1.15A 5kr2B-3hdfA:
undetectable
5kr2B-3hdfA:
19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DIF_B_TPVB201_0
(HIV-1 PROTEASE)
3hdf LYSOZYME
(Escherichia
virus
Lambda)
5 / 12 ALA A 131
ASP A 127
GLY A 163
PRO A  95
ILE A 123
None
1.06A 6difA-3hdfA:
undetectable
6difA-3hdfA:
18.12